annual net income:
-$4.03M-$57.85M(-107.49%)Summary
- As of today (September 13, 2025), LGND annual net profit is -$4.03 million, with the most recent change of -$57.85 million (-107.49%) on December 31, 2024.
- During the last 3 years, LGND annual net income has fallen by -$80.39 million (-105.28%).
- LGND annual net income is now -100.64% below its all-time high of $629.30 million, reached on December 31, 2019.
Performance
LGND Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$4.85M+$47.30M(+111.42%)Summary
- As of today (September 13, 2025), LGND quarterly net profit is $4.85 million, with the most recent change of +$47.30 million (+111.42%) on June 30, 2025.
- Over the past year, LGND quarterly net income has increased by +$56.76 million (+109.34%).
- LGND quarterly net income is now -99.27% below its all-time high of $666.34 million, reached on March 31, 2019.
Performance
LGND quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$75.86M+$56.76M(+42.80%)Summary
- As of today (September 13, 2025), LGND TTM net profit is -$75.86 million, with the most recent change of +$56.76 million (+42.80%) on June 30, 2025.
- Over the past year, LGND TTM net income has dropped by -$118.01 million (-280.02%).
- LGND TTM net income is now -109.92% below its all-time high of $764.38 million, reached on March 31, 2019.
Performance
LGND TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LGND Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -107.5% | +109.3% | -280.0% |
| 3 y3 years | -105.3% | -61.5% | -843.8% |
| 5 y5 years | -100.6% | -78.0% | -207.6% |
LGND Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -105.3% | +22.7% | -94.4% | +109.3% | -178.7% | +42.8% |
| 5 y | 5-year | -100.6% | +22.7% | -94.4% | +109.3% | -178.7% | +42.8% |
| alltime | all time | -100.6% | +97.0% | -99.3% | +103.4% | -109.9% | +57.1% |
LGND Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.85M(-111.4%) | -$75.86M(-42.8%) |
| Mar 2025 | - | -$42.45M(+36.6%) | -$132.62M(+3189.2%) |
| Dec 2024 | -$4.03M(-107.5%) | -$31.09M(+333.5%) | -$4.03M(-108.9%) |
| Sep 2024 | - | -$7.17M(-86.2%) | $45.24M(+7.4%) |
| Jun 2024 | - | -$51.91M(-160.3%) | $42.14M(-56.3%) |
| Mar 2024 | - | $86.14M(+373.6%) | $96.34M(+79.0%) |
| Dec 2023 | $53.82M(-1131.2%) | $18.19M(-277.0%) | $53.82M(+155.1%) |
| Sep 2023 | - | -$10.27M(-548.6%) | $21.10M(-48.6%) |
| Jun 2023 | - | $2.29M(-94.7%) | $41.02M(-20.1%) |
| Mar 2023 | - | $43.61M(-400.1%) | $51.32M(-1083.4%) |
| Dec 2022 | -$5.22M(-106.8%) | -$14.53M(-250.7%) | -$5.22M(-185.3%) |
| Sep 2022 | - | $9.64M(-23.4%) | $6.12M(-40.0%) |
| Jun 2022 | - | $12.60M(-197.4%) | $10.20M(-64.0%) |
| Mar 2022 | - | -$12.93M(+304.8%) | $28.32M(-52.3%) |
| Dec 2021 | $76.35M(-2657.9%) | -$3.19M(-123.3%) | $59.36M(-13.1%) |
| Sep 2021 | - | $13.72M(-55.3%) | $68.31M(+42.6%) |
| Jun 2021 | - | $30.73M(+69.7%) | $47.89M(+22.0%) |
| Mar 2021 | - | $18.11M(+214.3%) | $39.25M(-1415.0%) |
| Dec 2020 | -$2.98M(-100.5%) | $5.76M(-186.0%) | -$2.98M(-81.5%) |
| Sep 2020 | - | -$6.70M(-130.3%) | -$16.11M(-34.7%) |
| Jun 2020 | - | $22.09M(-191.5%) | -$24.66M(-59.7%) |
| Mar 2020 | - | -$24.13M(+227.6%) | -$61.17M(-109.7%) |
| Dec 2019 | $629.30M(+339.1%) | -$7.37M(-51.7%) | $629.30M(+5.9%) |
| Sep 2019 | - | -$15.25M(+5.8%) | $594.18M(-12.2%) |
| Jun 2019 | - | -$14.42M(-102.2%) | $676.80M(-11.5%) |
| Mar 2019 | - | $666.34M(-1668.5%) | $764.38M(+433.3%) |
| Dec 2018 | $143.32M(+1041.5%) | -$42.48M(-163.1%) | $143.32M(-19.8%) |
| Sep 2018 | - | $67.36M(-7.9%) | $178.79M(+49.2%) |
| Jun 2018 | - | $73.16M(+61.6%) | $119.86M(+127.2%) |
| Mar 2018 | - | $45.28M(-745.9%) | $52.75M(+320.2%) |
| Dec 2017 | $12.56M(-630.5%) | -$7.01M(-183.2%) | $12.55M(-23.6%) |
| Sep 2017 | - | $8.43M(+39.1%) | $16.44M(+81.4%) |
| Jun 2017 | - | $6.06M(+19.3%) | $9.06M(-386.2%) |
| Mar 2017 | - | $5.08M(-262.5%) | -$3.17M(+33.7%) |
| Dec 2016 | -$2.37M(-101.0%) | -$3.13M(-397.4%) | -$2.37M(-133.4%) |
| Sep 2016 | - | $1.05M(-117.0%) | $7.10M(-96.5%) |
| Jun 2016 | - | -$6.17M(-205.0%) | $205.21M(-12.1%) |
| Mar 2016 | - | $5.88M(-7.3%) | $233.41M(+2.6%) |
| Dec 2015 | $227.44M(+1988.2%) | $6.34M(-96.8%) | $227.44M(-0.2%) |
| Sep 2015 | - | $199.16M(+804.2%) | $227.84M(+673.7%) |
| Jun 2015 | - | $22.03M(<-9900.0%) | $29.45M(+238.1%) |
| Mar 2015 | - | -$89.00K(-101.3%) | $8.71M(-20.1%) |
| Dec 2014 | $10.89M(+23.3%) | $6.73M(+766.5%) | $10.89M(+80.6%) |
| Sep 2014 | - | $777.00K(-39.7%) | $6.03M(-16.5%) |
| Jun 2014 | - | $1.29M(-38.6%) | $7.22M(-25.0%) |
| Mar 2014 | - | $2.10M(+12.2%) | $9.63M(+9.0%) |
| Dec 2013 | $8.83M(-430.3%) | $1.87M(-4.9%) | $8.83M(-7.5%) |
| Sep 2013 | - | $1.97M(-46.8%) | $9.55M(+29.2%) |
| Jun 2013 | - | $3.69M(+183.3%) | $7.39M(-2097.3%) |
| Mar 2013 | - | $1.30M(-49.6%) | -$370.00K(-82.9%) |
| Dec 2012 | -$2.67M(-127.5%) | $2.59M(-1433.0%) | -$2.16M(-835.0%) |
| Sep 2012 | - | -$194.00K(-95.2%) | $294.00K(-108.0%) |
| Jun 2012 | - | -$4.07M(+734.9%) | -$3.69M(+585.9%) |
| Mar 2012 | - | -$487.00K(-109.7%) | -$538.00K(-105.4%) |
| Dec 2011 | $9.71M(-176.0%) | $5.04M(-220.7%) | $9.98M(+5.7%) |
| Sep 2011 | - | -$4.18M(+357.1%) | $9.44M(+432.1%) |
| Jun 2011 | - | -$914.00K(-109.1%) | $1.77M(-26.2%) |
| Mar 2011 | - | $10.03M(+122.7%) | $2.40M(-122.7%) |
| Dec 2010 | -$12.79M(+53.4%) | $4.50M(-138.0%) | -$10.61M(-24.7%) |
| Sep 2010 | - | -$11.84M(+4084.8%) | -$14.08M(+1087.5%) |
| Jun 2010 | - | -$283.00K(-90.5%) | -$1.19M(-78.0%) |
| Mar 2010 | - | -$2.99M(-389.9%) | -$5.38M(-45.5%) |
| Dec 2009 | -$8.34M | $1.03M(-2.3%) | -$9.87M(-88.3%) |
| Sep 2009 | - | $1.05M(-123.6%) | -$84.63M(-10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$4.48M(-40.2%) | -$94.81M(-0.4%) |
| Mar 2009 | - | -$7.48M(-89.9%) | -$95.22M(-2.3%) |
| Dec 2008 | -$97.46M(+180.4%) | -$73.73M(+708.1%) | -$97.46M(+235.5%) |
| Sep 2008 | - | -$9.12M(+86.6%) | -$29.05M(+17.2%) |
| Jun 2008 | - | -$4.89M(-49.7%) | -$24.79M(-10.1%) |
| Mar 2008 | - | -$9.72M(+82.6%) | -$27.59M(-20.6%) |
| Dec 2007 | -$34.76M(-74.4%) | -$5.32M(+9.5%) | -$34.76M(-410.5%) |
| Sep 2007 | - | -$4.86M(-36.7%) | $11.19M(<-9900.0%) |
| Jun 2007 | - | -$7.69M(-54.5%) | -$86.00K(-99.0%) |
| Mar 2007 | - | -$16.89M(-141.6%) | -$8.36M(-93.7%) |
| Dec 2006 | -$135.86M(+273.2%) | $40.63M(-351.7%) | -$133.70M(-24.5%) |
| Sep 2006 | - | -$16.14M(+1.1%) | -$177.05M(+5.9%) |
| Jun 2006 | - | -$15.96M(-88.8%) | -$167.19M(+4.4%) |
| Mar 2006 | - | -$142.23M(+5125.2%) | -$160.16M(+340.0%) |
| Dec 2005 | -$36.40M(-19.4%) | -$2.72M(-56.7%) | -$36.40M(+122.7%) |
| Sep 2005 | - | -$6.28M(-29.6%) | -$16.34M(-42.8%) |
| Jun 2005 | - | -$8.92M(-51.7%) | -$28.56M(-31.5%) |
| Mar 2005 | - | -$18.47M(-206.6%) | -$41.70M(-7.6%) |
| Dec 2004 | -$45.14M(+27.3%) | $17.33M(-193.7%) | -$45.14M(-17.2%) |
| Sep 2004 | - | -$18.50M(-16.2%) | -$54.53M(+15.7%) |
| Jun 2004 | - | -$22.07M(+0.7%) | -$47.12M(+27.2%) |
| Mar 2004 | - | -$21.91M(-375.7%) | -$37.05M(+4.5%) |
| Dec 2003 | -$35.46M(+8.8%) | $7.95M(-171.7%) | -$35.46M(-29.3%) |
| Sep 2003 | - | -$11.09M(-7.6%) | -$50.13M(+8.8%) |
| Jun 2003 | - | -$12.00M(-41.0%) | -$46.09M(-0.5%) |
| Mar 2003 | - | -$20.32M(+202.0%) | -$46.34M(+42.2%) |
| Dec 2002 | -$32.60M(-24.2%) | -$6.73M(-4.5%) | -$32.60M(-16.3%) |
| Sep 2002 | - | -$7.05M(-42.5%) | -$38.92M(-1.8%) |
| Jun 2002 | - | -$12.25M(+86.3%) | -$39.62M(+4.3%) |
| Mar 2002 | - | -$6.58M(-49.6%) | -$37.99M(-11.6%) |
| Dec 2001 | -$42.99M(-27.5%) | -$13.05M(+68.6%) | -$42.99M(+0.8%) |
| Sep 2001 | - | -$7.74M(-27.0%) | -$42.64M(-14.4%) |
| Jun 2001 | - | -$10.62M(-8.3%) | -$49.83M(-10.5%) |
| Mar 2001 | - | -$11.58M(-8.8%) | -$55.67M(-5.7%) |
| Dec 2000 | -$59.28M(-20.7%) | -$12.70M(-14.9%) | -$59.04M(-14.7%) |
| Sep 2000 | - | -$14.93M(-9.3%) | -$69.20M(-4.7%) |
| Jun 2000 | - | -$16.46M(+10.1%) | -$72.58M(-3.4%) |
| Mar 2000 | - | -$14.96M(-34.6%) | -$75.11M(+0.5%) |
| Dec 1999 | -$74.72M(-36.6%) | -$22.86M(+24.9%) | -$74.72M(-19.2%) |
| Sep 1999 | - | -$18.31M(-3.6%) | -$92.52M(-23.2%) |
| Jun 1999 | - | -$18.99M(+30.5%) | -$120.49M(+1.3%) |
| Mar 1999 | - | -$14.56M(-64.2%) | -$118.90M(+0.9%) |
| Dec 1998 | -$117.89M(+17.7%) | -$40.66M(-12.1%) | -$117.88M(-18.9%) |
| Sep 1998 | - | -$46.27M(+165.8%) | -$145.32M(+31.3%) |
| Jun 1998 | - | -$17.41M(+28.6%) | -$110.65M(+6.8%) |
| Mar 1998 | - | -$13.54M(-80.1%) | -$103.64M(+3.4%) |
| Dec 1997 | -$100.15M(+168.4%) | -$68.10M(+487.1%) | -$100.20M(+128.2%) |
| Sep 1997 | - | -$11.60M(+11.5%) | -$43.90M(+7.9%) |
| Jun 1997 | - | -$10.40M(+3.0%) | -$40.70M(+1.0%) |
| Mar 1997 | - | -$10.10M(-14.4%) | -$40.30M(+8.0%) |
| Dec 1996 | -$37.31M(-41.9%) | -$11.80M(+40.5%) | -$37.30M(+10.0%) |
| Sep 1996 | - | -$8.40M(-16.0%) | -$33.90M(-0.3%) |
| Jun 1996 | - | -$10.00M(+40.8%) | -$34.00M(-48.1%) |
| Mar 1996 | - | -$7.10M(-15.5%) | -$65.50M(+2.0%) |
| Dec 1995 | -$64.17M(+137.0%) | -$8.40M(-1.2%) | -$64.20M(+3.0%) |
| Sep 1995 | - | -$8.50M(-79.5%) | -$62.30M(+3.7%) |
| Jun 1995 | - | -$41.50M(+615.5%) | -$60.10M(+131.2%) |
| Mar 1995 | - | -$5.80M(-10.8%) | -$26.00M(-4.1%) |
| Dec 1994 | -$27.08M(+39.2%) | -$6.50M(+3.2%) | -$27.10M(+31.6%) |
| Sep 1994 | - | -$6.30M(-14.9%) | -$20.60M(+44.1%) |
| Jun 1994 | - | -$7.40M(+7.2%) | -$14.30M(+107.2%) |
| Mar 1994 | - | -$6.90M | -$6.90M |
| Dec 1993 | -$19.46M(+38.9%) | - | - |
| Dec 1992 | -$14.01M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual net profit?
- What is the all time high annual net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual net income year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly net profit?
- What is the all time high quarterly net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly net income year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM net profit?
- What is the all time high TTM net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM net income year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual net profit?
The current annual net income of LGND is -$4.03M
What is the all time high annual net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual net profit is $629.30M
What is Ligand Pharmaceuticals Incorporated annual net income year-on-year change?
Over the past year, LGND annual net profit has changed by -$57.85M (-107.49%)
What is Ligand Pharmaceuticals Incorporated quarterly net profit?
The current quarterly net income of LGND is $4.85M
What is the all time high quarterly net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly net profit is $666.34M
What is Ligand Pharmaceuticals Incorporated quarterly net income year-on-year change?
Over the past year, LGND quarterly net profit has changed by +$56.76M (+109.34%)
What is Ligand Pharmaceuticals Incorporated TTM net profit?
The current TTM net income of LGND is -$75.86M
What is the all time high TTM net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM net profit is $764.38M
What is Ligand Pharmaceuticals Incorporated TTM net income year-on-year change?
Over the past year, LGND TTM net profit has changed by -$118.01M (-280.02%)